1.
Clin Case Rep
; 9(2): 853-855, 2021 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33598258
RESUMO
The authors urge clinicians to balance the use of Immunosuppressant drugs and tocilizumab for COVID-19 patients to avoid the development of infections like Cryptococcemia, leading to death within 30 days.